| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HAMILTON THORNE Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 249,75 | +0,40 % | UnitedHealth-Aktie: Schockmeldung - droht der komplette Absturz? | ||
| MEDTRONIC | 80,49 | +0,42 % | Medtronic's MiniMed Group Prices IPO Of 28 Mln Shares At $20.00/shr | WASHINGTON (dpa-AFX) - MiniMed Group Inc., a subsidiary of Medtronic plc (MDT), announced the pricing of its initial public offering of 28 million shares of its common stock at a price to the... ► Artikel lesen | |
| INTUITIVE SURGICAL | 430,25 | +0,53 % | Intuitive Surgical: Steht ein weiterer Rücksetzer bevor? | Die Intuitive-Surgical-Aktie zeigt seit dem Jahreswechsel eine deutlich schwächere Struktur. Rutscht der Kurs in Richtung der nächsten Unterstützung ab Den vollständigen Artikel lesen ... ► Artikel lesen | |
| TELADOC HEALTH | 4,431 | +0,32 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 | ||
| SERNOVA BIOTHERAPEUTICS | 0,099 | +4,21 % | Sernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 4, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) ("Sernova" or the "Company"), a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| HCA HEALTHCARE | 458,90 | -0,39 % | Cantor Fitzgerald reiterates HCA Healthcare stock Overweight rating | ||
| LANTHEUS | 65,84 | +0,12 % | Lantheus receives FDA tentative approval for generic cancer drug | ||
| ENVISTA | 24,400 | +0,83 % | Envista Holdings Corporation: Envista Reports Fourth Quarter 2025 Results | BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2025.
"With our... ► Artikel lesen | |
| CAREDX | 15,640 | -3,25 % | CareDx skizziert Wachstumsstrategie: Expansion in der Transplantationsmedizin und Onkologie | ||
| GT BIOPHARMA | 0,460 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Reports Full Year 2025 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Second Quarter Fiscal Year 2026 Results | Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA
HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | CARMAT Provides an Update on the Ongoing Receivership Procedure | The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS
Regulatory News:
CARMAT... ► Artikel lesen | |
| CHEMOMETEC | 56,45 | +0,62 % | Chemometec A/S: Notification of managers' transactions |